BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 11, 2005
View Archived Issues
SR-141716 proves active in chronic neuropathic pain
Read More
XP-828L reported effective and safe in mild to moderate psoriasis
Read More
Treatment intervals of 4-7 days necessary for HuCAL-derived antibody efficacy
Read More
MEN-13510: A new selective NK2 receptor antagonist
Read More
FBCx reported to improve the lipid profile of obese patients with type 2 diabetes
Read More
GSK and Vitae form alliance in hypertension and cardiovascular disorders
Read More
KRX-101 enters pivotal phase III and phase IV programs
Read More
Phase III study evaluates Xifaxan in prevention of travelers' diarrhea
Read More
GTC Biotherapeutics files ATryn response to EMEA
Read More
Rigel gives low-down on pipeline
Read More
Agents for arthritis and other inflammatory disorders found in patent literature
Read More
Tarceva sNDA for pancreatic cancer granted priority review
Read More
Novartis and P&G to copromote Enablex in U.S.
Read More
European SPIRIT II trial begins enrollment
Read More
New treatments for respiratory disorders emerge from recent R&D
Read More
Doxycycline shows promise in the treatment of osteoarthritis
Read More
Schering AG announces completion of clinical trial with interferon beta-1b in early MS
Read More
FTY-720 reduces relapses in patients with relapsing multiple sclerosis
Read More
First phase I/II data with HuMax-CD20 in follicular non-Hodgkin's lymphoma
Read More
LymPro Test differentiates Alzheimer's from other dementia in pilot study
Read More
OSI grants DPP-IV license to Japanese company
Read More
IH-901 exerts antimetastatic effects in mice
Read More
Waiting period expires for Anadys' collaboration with Novartis
Read More
Long-term effects of CRX-675 in a dog model of allergic rhinitis
Read More
SPP-301 begins phase III for diabetic nephropathy
Read More
FDA approval for Aczone
Read More
Update on the antitumor efficacy of TG-4010 in NSCLC
Read More
